{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:44:33Z","timestamp":1772120673650,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T00:00:00Z","timestamp":1676678400000},"content-version":"vor","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EB023339"],"award-info":[{"award-number":["R01 EB023339"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EB028274"],"award-info":[{"award-number":["R01 EB028274"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.chembiol.2021.07.013","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T10:30:07Z","timestamp":1628245807000},"page":"328-338.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Engineered protein-small molecule conjugates empower selective enzyme inhibition"],"prefix":"10.1016","volume":"29","author":[{"given":"Andrew K.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7364-4304","authenticated-orcid":false,"given":"Abbigael","family":"Harthorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadie M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy R.","family":"Lobb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin J.","family":"Hackel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2021.07.013_bib1","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.chembiol.2005.08.018","article-title":"The binding of human carbonic anhydrase II by functionalized folded polypeptide receptors","volume":"12","author":"Andersson","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1021\/cb1003477","article-title":"Selection of carbonic anhydrase IX inhibitors from one million DNA-encoded compounds","volume":"6","author":"Buller","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib3","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.bmc.2011.04.005","article-title":"Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms i and II: solution and X-ray crystallographic studies","volume":"19","author":"Carta","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.chembiol.2021.07.013_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrd.2017.227","article-title":"Next generation antibody drugs\u202f: pursuit of the \u2018high-hanging fruit\u2019","volume":"17","author":"Carter","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2021.07.013_bib5","first-page":"1","article-title":"Target 2035: probing the human proteome","volume":"2513","author":"Carter","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.chembiol.2021.07.013_bib6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nprot.2006.94","article-title":"Isolating and engineering human antibodies using yeast surface display","volume":"1","author":"Chao","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chembiol.2021.07.013_bib7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/pro.2230","article-title":"Protein-protein interactions: general trends in the relationship between binding affinity and interfacial buried surface area","volume":"22","author":"Chen","year":"2013","journal-title":"Protein Sci."},{"key":"10.1016\/j.chembiol.2021.07.013_bib8","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41587-020-0733-7","article-title":"Identification of highly selective covalent inhibitors by phage display","volume":"39","author":"Chen","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature23912","article-title":"Massively parallel de novo protein design for targeted therapeutics","volume":"550","author":"Chevalier","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2021.07.013_bib10","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1021\/acs.biochem.7b00536","article-title":"Residue-specific peptide modification: a chemist\u2019s guide","volume":"56","author":"DeGruyter","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2021.07.013_bib11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cbpa.2019.03.014","article-title":"Genetically encoded fragment-based discovery","volume":"50","author":"Derda","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/protein\/gzw029","article-title":"A platform for constructing , evaluating , and screening bioconjugates on the yeast surface","volume":"29","author":"Deventer","year":"2016","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.chembiol.2021.07.013_bib13","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1093\/bioinformatics\/btq461","article-title":"Search and clustering orders of magnitude faster than BLAST","volume":"26","author":"Edgar","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.chembiol.2021.07.013_bib14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrd.2016.109","article-title":"Twenty years on: the impact of fragments on drug discovery","volume":"15","author":"Erlanson","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2021.07.013_bib15","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1021\/acs.bioconjchem.8b00252","article-title":"Covalent modification of biomolecules through maleimide-based labeling strategies","volume":"29","author":"Fredy","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.chembiol.2021.07.013_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nm1534","article-title":"Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation","volume":"13","author":"Gao","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2021.07.013_bib17","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1016\/j.bmcl.2004.07.087","article-title":"Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic\/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties","volume":"14","author":"Garaj","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.chembiol.2021.07.013_bib18","doi-asserted-by":"crossref","first-page":"7751","DOI":"10.1073\/pnas.1102294108","article-title":"Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design","volume":"108","author":"Gilbreth","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.chembiol.2021.07.013_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1021\/acschembio.5b00847","article-title":"Conversion of a single polypharmacological agent into selective bivalent inhibitors of intracellular kinase activity","volume":"11","author":"Gower","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib20","doi-asserted-by":"crossref","first-page":"e15962","DOI":"10.1371\/journal.pone.0015962","article-title":"A new peptide ligand for targeting human carbonic anhydrase IX, identified through the phage display technology","volume":"5","author":"Hebling","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2021.07.013_bib21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nchembio.184","article-title":"Phage-encoded combinatorial chemical libraries based on bicyclic peptides","volume":"5","author":"Heinis","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib22","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1021\/ja500678v","article-title":"Directed evolution of multivalent glycopeptides tightly recognized by HIV antibody 2G12","volume":"136","author":"Horiya","year":"2014","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2021.07.013_bib23","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1038\/s41467-021-23609-8","article-title":"Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites","volume":"12","author":"Hosseinzadeh","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2021.07.013_bib24","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.bmcl.2008.03.012","article-title":"Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates","volume":"18","author":"Innocenti","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.chembiol.2021.07.013_bib25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1021\/acschembio.0c00865","article-title":"Chemical diversification of simple synthetic antibodies","volume":"16","author":"Islam","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib26","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1073\/pnas.1616408114","article-title":"Biophysical properties of the clinical-stage antibody landscape","volume":"114","author":"Jain","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.chembiol.2021.07.013_bib27","first-page":"017","article-title":"Bacteriophage library displaying immunoglobulin repertoires with a chemical moiety covalently bound within the binding site: production and selection thereof","volume":"6","author":"Jespers","year":"1994","journal-title":"United States Patent"},{"key":"10.1016\/j.chembiol.2021.07.013_bib28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/protein\/gzh083","article-title":"Selection of optical biosensors from chemisynthetic antibody libraries","volume":"17","author":"Jespers","year":"2004","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.chembiol.2021.07.013_bib29","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jmb.2005.09.086","article-title":"A stable disulfide-free gene-3-protein of phage fd generated by in\u00a0vitro evolution","volume":"354","author":"Kather","year":"2005","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib30","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1006\/jmbi.1998.2238","article-title":"The fibronectin type III domain as a scaffold for novel binding proteins","volume":"284","author":"Koide","year":"1998","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib31","series-title":"Fragment-Based Approaches in Drug Discovery","first-page":"11","article-title":"Multivalency in ligand design","author":"Krishnamurthy","year":"2006"},{"key":"10.1016\/j.chembiol.2021.07.013_bib32","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/cr050262p","article-title":"Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding","volume":"108","author":"Krishnamurthy","year":"2008","journal-title":"Chem. Rev."},{"key":"10.1016\/j.chembiol.2021.07.013_bib33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1074-5521(03)00047-4","article-title":"A novel strategy for in\u00a0vitro selection of peptide-drug conjugates","volume":"10","author":"Li","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib34","first-page":"577","article-title":"A study of the kinetics of the reaction between thiol compounds and chloroacetamide","volume":"74","author":"Lindley","year":"1960","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2021.07.013_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.copbio.2003.10.011","article-title":"Non-canonical amino acids in protein engineering","volume":"14","author":"Link","year":"2003","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/protein\/gzq097","article-title":"Adnectins: engineered target-binding protein therapeutics","volume":"24","author":"Lipovsek","year":"2011","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.chembiol.2021.07.013_bib37","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jmb.2007.02.029","article-title":"Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: molecular convergence with single-domain camelid and shark antibodies","volume":"368","author":"Lipovsek","year":"2007","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.copbio.2004.05.004","article-title":"Novel methods for directed evolution of enzymes: quality, not quantity","volume":"15","author":"Lutz","year":"2004","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib39","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1002\/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3","article-title":"Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors","volume":"37","author":"Mammen","year":"1998","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.chembiol.2021.07.013_bib40","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tips.2006.09.002","article-title":"Targeting tumor-associated carbonic anhydrase IX in cancer therapy","volume":"27","author":"Masereel","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.chembiol.2021.07.013_bib41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"Mcdonald","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.chembiol.2021.07.013_bib42","doi-asserted-by":"crossref","first-page":"13812","DOI":"10.1021\/ja076197d","article-title":"Tethering small molecules to a phage display library: discovery of a selective bivalent inhibitor of protein kinase A","volume":"129","author":"Meyer","year":"2007","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2021.07.013_bib43","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.3390\/ijms21103661","article-title":"Synthetic strategies and computational inhibition activity study for triazinyl-substituted benzenesulfonamide conjugates with polar and hydrophobic amino acids as inhibitors of carbonic anhydrases","volume":"21","author":"Mikulov\u00e1","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chembiol.2021.07.013_bib44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bioorg.2018.08.005","article-title":"Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX","volume":"81","author":"Miku\u0161","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.chembiol.2021.07.013_bib45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nchem.217","article-title":"The rise of fragment-based drug discovery","volume":"1","author":"Murray","year":"2009","journal-title":"Nat. Chem."},{"key":"10.1016\/j.chembiol.2021.07.013_bib46","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/bioinformatics\/btx584","article-title":"Protein \u2013 protein interaction specificity is captured by contact preferences and interface composition","volume":"34","author":"Nadalin","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.chembiol.2021.07.013_bib47","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1021\/jacs.9b10716","article-title":"Directed evolution using stabilized bacterial peptide display","volume":"142","author":"Navaratna","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2021.07.013_bib48","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.1021\/ja511237n","article-title":"Genetically encoded fragment-based discovery of glycopeptide ligands for carbohydrate-binding proteins","volume":"137","author":"Ng","year":"2015","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2021.07.013_bib49","first-page":"1","article-title":"Affinity selections of DNA-encoded chemical libraries on carbonic anhydrase IX-expressing tumor cells reveal a dependence on ligand valence","volume":"27","author":"Oehler","year":"2021","journal-title":"Chemistry (Easton)."},{"key":"10.1016\/j.chembiol.2021.07.013_bib50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrg3927","article-title":"Methods for the directed evolution of proteins","volume":"16","author":"Packer","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.chembiol.2021.07.013_bib51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/83028","article-title":"Mechanism-based design of a protein kinase inhibitor","volume":"8","author":"Parang","year":"2001","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib52","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.chembiol.2021.07.013_bib54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/14756360410001689540","article-title":"Carbonic anhydrases: current state of the art , therapeutic applications and future prospects","volume":"19","author":"Pastorekova","year":"2004","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.chembiol.2021.07.013_bib55","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.bjc.6600936","article-title":"Diagnostic , prognostic and therapeutic implications of carbonic anhydrases in cancer","volume":"89","author":"Potter","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.chembiol.2021.07.013_bib56","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4161\/mabs.25211","article-title":"Highly efficient selection of epitope specific antibody through competitive yeast display library sorting","volume":"5","author":"Puri","year":"2013","journal-title":"MAbs"},{"key":"10.1016\/j.chembiol.2021.07.013_bib57","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"Rafajov","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.chembiol.2021.07.013_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2310\/7290.2013.00066","article-title":"Screening of a novel peptide targeting the proteoglycan-like region of human carbonic anhydrase IX","volume":"12","author":"Rana","year":"2013","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.chembiol.2021.07.013_bib59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/chem.201803174","article-title":"Bioconjugation with maleimides: a useful tool for chemical biology","volume":"25","author":"Ravasco","year":"2019","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.chembiol.2021.07.013_bib60","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrd.2016.123","article-title":"Biophysics in drug discovery: impact, challenges and opportunities","volume":"15","author":"Renaud","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2021.07.013_bib61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.sbi.2015.06.002","article-title":"Structural and genetic diversity in antibody repertoires from diverse species","volume":"33","author":"de los Rios","year":"2015","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib62","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1158\/0008-5472.CAN-03-2224","article-title":"Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion","volume":"64","author":"Robertson","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.chembiol.2021.07.013_bib63","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.xphs.2015.11.037","article-title":"Physical and chemical stability of antibody drug conjugates: current status","volume":"105","author":"Ross","year":"2016","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.chembiol.2021.07.013_bib64","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1021\/ol050179o","article-title":"Increasing the kinase specificity of K252a by protein surface recognition","volume":"7","author":"Schneider","year":"2005","journal-title":"Org. Lett."},{"key":"10.1016\/j.chembiol.2021.07.013_bib65","doi-asserted-by":"crossref","first-page":"10690","DOI":"10.1021\/ja00053a002","article-title":"The cost of conformational order: entropy changes in molecular associations","volume":"114","author":"Searle","year":"1992","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2021.07.013_bib66","first-page":"168","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib67","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.chembiol.2021.07.013_bib68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.chembiol.2021.07.013_bib69","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/med.21497","article-title":"Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one","volume":"38","author":"Supuran","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.chembiol.2021.07.013_bib70","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1074\/jbc.M111.286062","article-title":"Carbonic anhydrase IX interacts with bicarbonate transporters in lamellipodia and increases cell migration via its catalytic domain","volume":"287","author":"Svastova","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2021.07.013_bib71","doi-asserted-by":"crossref","first-page":"15962","DOI":"10.1021\/ja045673m","article-title":"A phage display system with unnatural amino acids","volume":"126","author":"Tian","year":"2004","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2021.07.013_bib72","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jmb.2007.03.069","article-title":"The stability effects of protein mutations appear to be universally distributed","volume":"369","author":"Tokuriki","year":"2007","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/bp990133s","article-title":"Fine affinity discrimination by yeast surface display and flow cytometry","volume":"16","author":"VanAntwerp","year":"2000","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.chembiol.2021.07.013_bib74","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/bph.12106","article-title":"Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands","volume":"168","author":"Vauquelin","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib75","doi-asserted-by":"crossref","first-page":"24856","DOI":"10.18632\/oncotarget.4498","article-title":"Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in\u00a0vitro breast cancer models","volume":"6","author":"Ward","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.chembiol.2021.07.013_bib76","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev.iy.12.040194.002245","article-title":"Making antibodies by phage display technology","volume":"12","author":"Winter","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib77","doi-asserted-by":"crossref","first-page":"e0138956","DOI":"10.1371\/journal.pone.0138956","article-title":"High-throughput ligand discovery reveals a sitewise gradient of diversity in broadly evolved hydrophilic fibronectin domains","volume":"10","author":"Woldring","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2021.07.013_bib78","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1039\/D0CB00167H","article-title":"Strategies to expand peptide functionality through hybridisation with a small molecule component","volume":"2","author":"Wu","year":"2021","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.chembiol.2021.07.013_bib79","doi-asserted-by":"crossref","first-page":"21295","DOI":"10.1073\/pnas.1211762109","article-title":"Heterobivalent ligands target cell-surface receptor combinations in\u00a0vivo","volume":"109","author":"Xu","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.chembiol.2021.07.013_bib80","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1126\/science.1136782","article-title":"Computational design of peptides that target transmembrane helices","volume":"315","author":"Yin","year":"2007","journal-title":"Science"}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945621003536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945621003536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:41:42Z","timestamp":1762526502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945621003536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2451945621003536"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2021.07.013","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.05.05.442679","asserted-by":"object"}]},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered protein-small molecule conjugates empower selective enzyme inhibition","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2021.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}